Product Information
XARAH FE 1 MG/20-30-35 MCG TAB is a generic product labeled by Xiromed LLC, priced at $0.7459 per EA under NDC 70700031085. Its NADAC has been published 60 times since Aug 13, 2025.
FDA first approved this application on Jun 22, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
XARAH FE 1 MG/20-30-35 MCG TAB
norethindrone acetate and ethinyl estradiol and ferrous fumarate tabletsManufacturer
Xiromed LLCNDC
70700031085
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205069FDA Approved
6/22/2018
TE Code
AB
On Market Since
1/29/2025
Price Statistics
The NADAC for XARAH FE 1 MG/20-30-35 MCG TAB has been published 60 times since Aug 13, 2025, and over the history we have for it it has declined 35.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7459 per EA |
|---|---|
| All-time high | $1.1890 (Oct 15, 2025) |
| All-time low | $0.7459 (Sep 23, 2026) |
| 52-week high | $1.1890 |
| 52-week low | $0.7459 |
| Median price | $1.0566 |
| Average price | $0.9909 |
| Largest weekly change | -11.1% (Apr 22, 2026) |
| Weeks tracked | 60 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the norethindrone acetate and ethinyl estradiol and ferrous fumarate tablets market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
norethindrone acetate and ethinyl estradiol and ferrous fumarate tablets market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XARAH FE 1 MG/20-30-35 MCG TAB?
The current National Average Drug Acquisition Cost (NADAC) for XARAH FE 1 MG/20-30-35 MCG TAB, manufactured by Xiromed LLC, is $0.7459 per EA (NDC 70700031085), effective Sep 30, 2026.
How has the price of XARAH FE 1 MG/20-30-35 MCG TAB changed over time?
Over the history we have for it, the NADAC for XARAH FE 1 MG/20-30-35 MCG TAB has declined 35.0%. It has been tracked across 60 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for XARAH FE 1 MG/20-30-35 MCG TAB?
Since Aug 13, 2025, the NADAC for XARAH FE 1 MG/20-30-35 MCG TAB has ranged from a low of $0.7459 (Sep 23, 2026) to a high of $1.1890 (Oct 15, 2025), with a median of $1.0566 per EA.
Are there cheaper alternatives to XARAH FE 1 MG/20-30-35 MCG TAB?
No other NADAC-published product currently shares the active ingredient and strength of XARAH FE 1 MG/20-30-35 MCG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XARAH FE 1 MG/20-30-35 MCG TAB?
XARAH FE 1 MG/20-30-35 MCG TAB (NDC 70700031085) is labeled by Xiromed LLC, and CMS classifies it as a generic product.